Barclays’s Idexx Laboratories IDXX Stock Holding History

Barclays’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-92,600	Closed	-$38.9M	–	5395
2025 Q1	$38.9M	Buy	+92,600	New	+$40.2M	0.01%	757
2024 Q4	–	Sell	-103,000	Closed	-$52M	–	5368
2024 Q3	$52M	Buy	+103,000	New	+$50M	0.01%	654
2019 Q1	–	Sell	-200	Closed	-$37K	–	7147
2018 Q4	$37K	Buy	+200	New	+$41K	﹤0.01%	5629
2018 Q3	–	Sell	-7,000	Closed	-$1.53M	–	7238
2018 Q2	$1.53M	Buy	+7,000	New	+$1.44M	﹤0.01%	2822
2017 Q1	–	Sell	-200	Closed	-$23K	–	6849
2016 Q4	$23K	Buy	+200	New	+$22.8K	﹤0.01%	5552

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays's IDXX Position: Q1 2026 in Review

Barclays reduced its Idexx Laboratories (IDXX) stake by 11% in Q1 2026, selling an estimated $15.2M and leaving 187,715 shares worth $105M. The position accounts for 0.03% of the portfolio, ranked #474.

Barclays first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $229M in Q3 2024. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Barclays held 187,715 shares of Idexx Laboratories worth $105M as of Q1 2026.
Barclays sold 23,723 Idexx Laboratories shares in Q1 2026, an estimated $15.2M.
Idexx Laboratories made up 0.03% of Barclays's portfolio in Q1 2026, its #474 holding.
Barclays first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
Barclays's Idexx Laboratories position peaked at $229M in Q3 2024.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.